Z
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
SZSE:300357
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
SZSE:300357
Price:
27.36
CNY
0.11%
Market Closed
Market Cap:
¥14.3B
Relative Value
The Relative Value of one Zhejiang Wolwo Bio-Pharmaceutical Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 27.36 CNY, Zhejiang Wolwo Bio-Pharmaceutical Co Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd Competitors
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
Z
|
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
SZSE:300357
|
14.3B CNY | 13.7 | 36.7 | 33.4 | 33.4 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
953.8B USD | 14.8 | 46.7 | 31.5 | 33.5 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
584.6B USD | 6.2 | 21.9 | 15.2 | 18.6 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
290.5B CHF | 4.7 | 30.9 | 13 | 15.2 | |
| CH |
|
Novartis AG
SIX:NOVN
|
245.6B CHF | 5.6 | 22.7 | 14 | 18 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
234.2B GBP | 5.4 | 30.8 | 17.1 | 24.1 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
296.8B USD | 4.6 | 16.3 | 10.2 | 12 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 344.9 | 865 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.4 | 7.7 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.7B USD | 2.5 | 19.9 | 7.4 | 9.9 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
122.5B USD | 2.6 | 17.4 | 7.3 | 9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
